About the Authors
- Yang Liu
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Phong Quang
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Esteban Braggio
-
Affiliation Department of Medicine, Division of Haematology, Mayo Clinic College of Medicine, Scottsdale, Arizona, United States of America
- Hai Ngo
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Gayane Badalian-Very
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Ludmila Flores
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Yong Zhang
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Antonio Sacco
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Patricia Maiso
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Abdel Kareem Azab
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Feda Azab
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Ruben Carrasco
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Barrett J. Rollins
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Aldo M. Roccaro
-
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
- Irene M. Ghobrial
-
* E-mail: irene_ghobrial@dfci.harvard.edu
Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
Competing Interests
There is no competing interest related to this article.
Author Contributions
Conceived and designed the experiments: YL, PQ, EB, HN, RC, BR, AR, IG. Performed the experiments: YL, PQ, EB, HN, GB, LF, YZ, AS, PM, AA, FA, RC. Analyzed the data: YL, PQ, EB, AR, IG. Contributed reagents/materials/analysis tools: EB, GB, LF, RC, BR. Wrote the manuscript: YL, EB, AR, IG.